The U.S. Food and Drug Administration on Tuesday warned eight companies, including pharmacy giants CVS Health Corp and Walgreens Boots Alliance , against manufacturing or marketing unapproved eye products.
The eye products addressed in the FDA'sare illegally marketed to treat conditions like conjunctivitis, cataract and glaucoma, the agency said, adding that such drugs pose an increased risk to users as they can bypass some of the body's natural defenses.
CVS on Tuesday said it has stopped the sale of its "Pink Eye Relief Eye Drops", and that customers who purchased the product could return it to the company's pharmacy for a full refund.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA warns CVS, Walgreens about marketing of unapproved eye productsThe U.S. Food and Drug Administration this week warned CVS Health Corp. Walgreens Boots Alliance Inc. and several smaller consumer products companies about...
Les mer »
FDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products By ReutersFDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products
Les mer »
When Should You Get the New COVID Booster?The Food and Drug Administration (FDA) approved a new round of COVID boosters on Monday.
Les mer »
4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe By Investing.com4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe
Les mer »
Here are Tuesday's biggest analyst calls: Nvidia, Tesla, CVS, Oracle, Walmart, Meta, Disney and moreHere are the biggest calls on Wall Street on Tuesday.
Les mer »
SA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Les mer »